Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma.

Source:http://linkedlifedata.com/resource/pubmed/id/7636537

Download in:

View as

General Info

PMID
7636537